Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare.

Through this collaboration, Beckman Coulter will benefit from observing Johns Hopkins' researchers and clinicians as they work to develop new technologies and concepts, which represent medical breakthroughs that can potentially help patients. Moreover, they will be able to test solutions on-site with experts who are working toward better patient care. Eventually, these solutions may be brought to market and could contribute to elevating healthcare throughout the nation.

Johns Hopkins' faculty, students and start-up community are expected to benefit from Beckman Coulter Diagnostics' expertise in global commercialization of diagnostic solutions. This should help accelerate the translational process from world-class research to healthcare application.